Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 23.3B | 26.1B | 24.5B | 22.8B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 3.9B | 4.4B | 3.8B | 4.2B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 8.1B | 8.2B | 9.4B | 9.2B |
| Tax provision | 1.7B | 2.0B | 2.4B | 2.4B |
| Net income | 6.4B | 6.3B | 7.0B | 6.9B |
| Basic EPS | — | 2.5 | 2.8 | 2.8 |
| Diluted EPS | — | 2.5 | 2.8 | 2.7 |
| Basic average shares | — | 2.5B | 2.5B | 2.5B |
| Diluted average shares | — | 2.5B | 2.5B | 2.5B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | 3.3M | 7.5M | -11M | 2.6M |
| Preferred stock dividends | — | — | — | — |